Flow Traders U.S.’s Boston Scientific BSX Stock Holding History

Flow Traders U.S.’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,252	Closed	-$201K	–	949
2024 Q4	$201K	Buy	+2,252	New	+$198K	0.01%	877

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Flow Traders U.S.'s BSX Position: Q1 2025 in Review

Flow Traders U.S. sold out of Boston Scientific (BSX) in Q1 2025, closing a stake of 2,252 shares — an estimated $201K sold.

Flow Traders U.S. first reported a position in BSX in Q4 2024 and held it in 1 quarter. The position peaked at $201K in Q4 2024. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

Flow Traders U.S. reported no remaining Boston Scientific position as of Q1 2025 after selling out during the quarter.
Flow Traders U.S. sold 2,252 Boston Scientific shares in Q1 2025, an estimated $201K.
Flow Traders U.S. first reported a position in Boston Scientific in Q4 2024 and held it in 1 quarter.
Flow Traders U.S.'s Boston Scientific position peaked at $201K in Q4 2024.
1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Flow Traders U.S.'s 13F filing for Q1 2025, filed 14 May 2025.